CN101200766A - 检测乳腺癌易感基因突变的多重pcr试剂盒及其制备方法 - Google Patents
检测乳腺癌易感基因突变的多重pcr试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN101200766A CN101200766A CNA2007101610442A CN200710161044A CN101200766A CN 101200766 A CN101200766 A CN 101200766A CN A2007101610442 A CNA2007101610442 A CN A2007101610442A CN 200710161044 A CN200710161044 A CN 200710161044A CN 101200766 A CN101200766 A CN 101200766A
- Authority
- CN
- China
- Prior art keywords
- exon
- primer
- brca2
- brca1
- breast cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010006187 Breast cancer Diseases 0.000 title claims abstract description 40
- 208000026310 Breast neoplasm Diseases 0.000 title claims abstract description 39
- 239000012807 PCR reagent Substances 0.000 title claims description 16
- 206010064571 Gene mutation Diseases 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 101150072950 BRCA1 gene Proteins 0.000 claims abstract description 36
- 101150008921 Brca2 gene Proteins 0.000 claims abstract description 35
- 108700020463 BRCA1 Proteins 0.000 claims description 31
- 102000036365 BRCA1 Human genes 0.000 claims description 30
- 102000052609 BRCA2 Human genes 0.000 claims description 30
- 108700020462 BRCA2 Proteins 0.000 claims description 30
- 239000013642 negative control Substances 0.000 claims description 14
- 239000013641 positive control Substances 0.000 claims description 14
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 10
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 10
- 239000011535 reaction buffer Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000007403 mPCR Methods 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 27
- 108090000623 proteins and genes Proteins 0.000 abstract description 23
- 238000001514 detection method Methods 0.000 abstract description 11
- 238000012408 PCR amplification Methods 0.000 abstract description 10
- 230000035772 mutation Effects 0.000 abstract description 10
- 108700010154 BRCA2 Genes Proteins 0.000 abstract description 6
- 108700040618 BRCA1 Genes Proteins 0.000 abstract description 5
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000009004 PCR Kit Methods 0.000 abstract 2
- 208000002109 Argyria Diseases 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 239000000523 sample Substances 0.000 description 8
- 108700024394 Exon Proteins 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 206010061535 Ovarian neoplasm Diseases 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 206010033128 Ovarian cancer Diseases 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 208000033640 Hereditary breast cancer Diseases 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000025581 hereditary breast carcinoma Diseases 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- -1 methane amide Chemical class 0.000 description 2
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 206010061020 Breast cancer male Diseases 0.000 description 1
- 230000005971 DNA damage repair Effects 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000014804 familial ovarian cancer Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101610442A CN101200766B (zh) | 2007-12-24 | 2007-12-24 | 检测乳腺癌易感基因突变的多重pcr试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101610442A CN101200766B (zh) | 2007-12-24 | 2007-12-24 | 检测乳腺癌易感基因突变的多重pcr试剂盒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101200766A true CN101200766A (zh) | 2008-06-18 |
CN101200766B CN101200766B (zh) | 2012-06-06 |
Family
ID=39516116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101610442A Expired - Fee Related CN101200766B (zh) | 2007-12-24 | 2007-12-24 | 检测乳腺癌易感基因突变的多重pcr试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101200766B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101985662A (zh) * | 2010-12-10 | 2011-03-16 | 苏州大学 | 一种检测乳腺癌易感性的试剂盒 |
CN104946751A (zh) * | 2015-06-02 | 2015-09-30 | 南京医科大学 | BRCA1基因g.41244291delT突变及其在乳腺癌辅助诊断中的应用 |
CN104988141A (zh) * | 2015-06-02 | 2015-10-21 | 南京医科大学 | BRCA2基因g.32912799T>C突变及其在乳腺癌辅助诊断中的应用 |
CN106367481A (zh) * | 2016-08-26 | 2017-02-01 | 广州永诺健康科技有限公司 | 一种扩增brca1/2基因的多重pcr引物及一种多重pcr引物的设计方法 |
CN107849612A (zh) * | 2015-03-26 | 2018-03-27 | 奎斯特诊断投资股份有限公司 | 比对和变体测序分析管线 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1920054A (zh) * | 2006-06-23 | 2007-02-28 | 南京中医药大学附属医院 | 乳腺癌基因1(brca1)突变检测分析 |
-
2007
- 2007-12-24 CN CN2007101610442A patent/CN101200766B/zh not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101985662A (zh) * | 2010-12-10 | 2011-03-16 | 苏州大学 | 一种检测乳腺癌易感性的试剂盒 |
CN101985662B (zh) * | 2010-12-10 | 2012-11-21 | 苏州大学 | 一种检测乳腺癌易感性的试剂盒 |
CN107849612A (zh) * | 2015-03-26 | 2018-03-27 | 奎斯特诊断投资股份有限公司 | 比对和变体测序分析管线 |
CN104946751A (zh) * | 2015-06-02 | 2015-09-30 | 南京医科大学 | BRCA1基因g.41244291delT突变及其在乳腺癌辅助诊断中的应用 |
CN104988141A (zh) * | 2015-06-02 | 2015-10-21 | 南京医科大学 | BRCA2基因g.32912799T>C突变及其在乳腺癌辅助诊断中的应用 |
CN104988141B (zh) * | 2015-06-02 | 2017-10-31 | 南京医科大学 | BRCA2基因g.32912799T>C突变及其在乳腺癌辅助诊断中的应用 |
CN104946751B (zh) * | 2015-06-02 | 2018-06-22 | 南京医科大学 | BRCA1基因g.41244291delT突变及其在乳腺癌辅助诊断中的应用 |
CN106367481A (zh) * | 2016-08-26 | 2017-02-01 | 广州永诺健康科技有限公司 | 一种扩增brca1/2基因的多重pcr引物及一种多重pcr引物的设计方法 |
CN106367481B (zh) * | 2016-08-26 | 2019-11-08 | 广州永诺健康科技有限公司 | 一种扩增brca1/2基因的多重pcr引物及一种多重pcr引物的设计方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101200766B (zh) | 2012-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tomaz et al. | FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility | |
JP6989863B2 (ja) | 大腸癌の診断方法 | |
Rahbari et al. | Identification of differentially expressed microRNA in parathyroid tumors | |
CN103436606B (zh) | 一种用于食管癌辅助诊断和/或预后判断的试剂盒 | |
Jin et al. | Up-regulation of ECT2 is associated with poor prognosisn gastric cancer patients | |
Heesch et al. | Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia | |
CN102388151A (zh) | 用于鉴定、分类和监控具有bcl-2家族抑制剂抗性肿瘤和癌症的受试者的方法和组合物 | |
Li et al. | A genome‐wide SNP scan reveals two loci associated with the chicken resistance to Marek's disease | |
CN104745681A (zh) | 多元基因组合物及其用途 | |
CN101200766B (zh) | 检测乳腺癌易感基因突变的多重pcr试剂盒及其制备方法 | |
Langevin et al. | Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma | |
Garavelli et al. | Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22. 3 microdeletion encompassing the PTCH1 and FANC‐C loci | |
WO1994019492A1 (en) | Tumor-specific genomic instability as a prognostic indicator | |
CN107099584A (zh) | 一种与结直肠癌转移及预后相关的分子标记物及其应用 | |
CN105420393A (zh) | 检测brca1基因表达的引物、探针及试剂盒 | |
CN101880715B (zh) | 一种肝癌肝移植术后复发预测试剂盒 | |
CN106319062B (zh) | 一种用于甲状腺癌辅助诊断或疗效预测的微创试剂盒 | |
CN107012232A (zh) | 用于检测胃癌易感性相关的snp位点的引物及检测方法 | |
Pirisi et al. | Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients | |
Jong et al. | Chromosomal comparative genomic hybridization abnormalities in early-and late-onset human breast cancers: correlation with disease progression and TP53 mutations | |
US20080119367A1 (en) | Prognosis of Renal Cell Carcinoma | |
CN102021228B (zh) | 用于组织或全血egfr基因突变检测的特异性引物 | |
ES2541054T3 (es) | Firmas del resultado clínico en tumores estromales gastrointestinales y método de tratamiento de tumores estromales gastrointestinales | |
CN103789436B (zh) | 一种基于人工修饰引物的定量突变检测*** | |
US20140011696A1 (en) | Bap1 mutational analysis in determining susceptibility to, prognosis of, and treatment of melanocytic neoplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING COMPULIFE BIOTECH RESEARCH CENTER Free format text: FORMER OWNER: HEILONGJIANG MEIKANG HUIRONG BIOTECHNOLOGY CO., LTD. Effective date: 20120328 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 150090 HARBIN, HEILONGJIANG PROVINCE TO: 100067 FENGTAI, BEIJING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120328 Address after: 100067, No. 5, building 15, No. 188, Fengtai science and Technology City, No. 8 South Fourth Ring Road, Beijing, Fengtai District Applicant after: Beijing Compulife Biotech Research Center Address before: 150090, No. 166, three Hanjiang Road, Nangang District, Heilongjiang, Harbin Applicant before: Heilongjiang Meikang Huirong Biotechnology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Beijing Meikang biological technology research center responsible person Document name: Notification that Application Deemed not to be Proposed |
|
C56 | Change in the name or address of the patentee |
Owner name: BEIJING MOKOBIO BIOTECHNOLOGY RESEARCH CENTER CO., Free format text: FORMER NAME: BEIJING COMPULIFE BIOTECH RESEARCH CENTER |
|
CP03 | Change of name, title or address |
Address after: 100070, Beijing, Fengtai District, No. 188 South Fourth Ring Road headquarters base, No. 15, zone 5, building 8 Patentee after: BEIJING MOKOBIO BIOTECHNOLOGY RESEARCH CENTER Co.,Ltd. Address before: 100067, No. 5, building 15, No. 188, Fengtai science and Technology City, No. 8 South Fourth Ring Road, Beijing, Fengtai District Patentee before: Beijing Compulife Biotech Research Center |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080618 Assignee: NANJING MOKOBIO BIOTECHNOLOGY CO.,LTD. Assignor: BEIJING MOKOBIO BIOTECHNOLOGY RESEARCH CENTER Co.,Ltd. Contract record no.: 2014990000876 Denomination of invention: Multiple PCR reagent kit detecting breast cancer susceptibility gene mutation and preparation method thereof Granted publication date: 20120606 License type: Exclusive License Record date: 20141121 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100070, Beijing, Fengtai District, No. 188 South Fourth Ring Road headquarters base, No. 15, zone 5, building 8 Patentee after: BEIJING MOKOBIO LIFE SCIENCE Co.,Ltd. Address before: 100070, Beijing, Fengtai District, No. 188 South Fourth Ring Road headquarters base, No. 15, zone 5, building 8 Patentee before: BEIJING MOKOBIO BIOTECHNOLOGY RESEARCH CENTER Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120606 |